|
 | 金鹰医疗健康产业A(004040)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2024-03-31 | 688062 | 迈威生物-U | 128.07 | 4485.15 | 24.64% | | 2024-03-31 | 688687 | 凯因科技 | 137.48 | 4429.65 | 24.34% | | 2024-03-31 | 300765 | 新诺威 | 114.80 | 4247.60 | 23.34% | | 2024-03-31 | 688331 | 荣昌生物 | 78.03 | 4203.64 | 23.10% | | 2024-03-31 | 688506 | 百利天恒-U | 31.55 | 3961.67 | 21.77% | | 2024-03-31 | 688443 | 智翔金泰-U | 96.58 | 3889.44 | 21.37% | | 2024-03-31 | 688192 | 迪哲医药-U | 81.27 | 3656.28 | 20.09% | | 2024-03-31 | 688266 | 泽璟制药-U | 59.25 | 3193.73 | 17.55% | | 2024-03-31 | 688235 | 百济神州-U | 21.11 | 2790.76 | 15.33% | | 2024-03-31 | 600276 | 恒瑞医药 | 57.08 | 2623.78 | 14.42% | |
|